Long-Term Lamivudine Therapy for Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 11, 2005

Study Completion Date

March 31, 2007

Conditions

Hepatitis B, Chronic

Interventions

PROCEDURE

Blood Testing

PROCEDURE

Percutaneous Liver Biopsy

PROCEDURE

Lamivudine Therapy

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00120354 - Long-Term Lamivudine Therapy for Chronic Hepatitis B | Biotech Hunter | Biotech Hunter